Vδ2 T cell deficiency in granulomatosis with polyangiitis (Wegener's granulomatosis)

Juliane Fazio, Elgar Susanne Quabius, Antje Müller, Sabine Adam-Klages, Daniela Wesch, Susanne Sebens, Shirin Kalyan, Peter Lamprecht, Dieter Kabelitz*

*Corresponding author for this work
7 Citations (Scopus)

Abstract

Previous studies have characterized phenotypic and functional alterations within T-cell receptor αβ-expressing T cells in patients with granulomatosis with polyangiitis (GPA). We analyzed the frequency, subset composition and in vitro activation of blood γδ T cells in GPA patients. We observed a significant reduction of γδ T cell numbers, due to the selective depletion of the Vδ2 subset which remained consistent over time upon repeated analysis. The loss of Vδ2 T cells was not due to migration into the inflamed lesions as very few γδ T cells were detected in inflammatory infiltrates. The memory subset distribution did not differ among Vδ2 T cells from healthy donors and GPA patients. Importantly, the remaining Vδ2 T cells were capable of responding to phosphoantigen stimulation in vitro. The marked depletion of blood Vδ2 T cells in GPA suggests cellular exhaustion, possibly due to chronic exposure to and continuous overstimulation by microbial phosphoantigens.

Original languageEnglish
JournalClinical Immunology
Volume149
Issue number1
Pages (from-to)65-72
Number of pages8
ISSN1521-6616
DOIs
Publication statusPublished - 01.10.2013

Funding

PL and DK were supported by the Deutsche Forschungsgemeinschaft ( KFO170 , project 3) and the Cluster of Excellence Inflammation-at-Interfaces , and SK by a fellowship from the Alexander-von-Humboldt Foundation . This work forms part of the Ph.D. thesis of JF.

Fingerprint

Dive into the research topics of 'Vδ2 T cell deficiency in granulomatosis with polyangiitis (Wegener's granulomatosis)'. Together they form a unique fingerprint.
  • CRU 170: Early Pathogenesis of Wegener's Granulomatosis: From Innate Immunity with Granuloma Formation to Autoimmunity.

    Gross, W. (Speaker, Coordinator), Lamprecht, P. (Speaker, Coordinator), Ambrosch, P. (Principal Investigator (PI)), Gottschlich, S. (Principal Investigator (PI)), Müller, A. (Principal Investigator (PI)), Ullrich, M. S. (Principal Investigator (PI)), Wieczorek, S. (Principal Investigator (PI)), Kabelitz, D. (Principal Investigator (PI)), Holle, J. (Principal Investigator (PI)), Ehlers, S. (Principal Investigator (PI)) & Moosig, F. (Principal Investigator (PI))

    01.01.0731.12.15

    Project: DFG Joint ResearchDFG Clinical Research Units (CRU)

Cite this